Till innehåll

Advancing NAMs: From Creation of Human-Relevant Models to Real-World Adoption

Date & time: 2026-12-01 16:30:00

CET

Hosted by:

Zack Graham, CELLINK

About the Session

New Approach Methodologies (NAMs) are reshaping how researchers study human biology, evaluate therapeutics and reduce reliance on animal testing. As interest in vitro human-relevant 3D models grows, so does the conversation around biological relevance, reproducibility, scalability, validation and what is needed to support broader adoption.

In this roundtable, experts will discuss where human-relevant in vitro models can have the greatest impact across biomedical research and the drug development workflow, what is driving their adoption, and what is still holding it back. The conversation will explore how enabling technologies, including 3D bioprinting, can support the development and wider use of these models, as well as what is needed to translate promising approaches into reliable, scalable and decision-relevant research tools.

Panelists

Prof. Dr. Jens Kurreck
Professor of Applied Biochemistry & Managing Director, Institute of Biotechnology, Technische Universität Berlin
Prof. Dr. Jens Kurreck is Professor of Applied Biochemistry and Managing Director of the Institute of Biotechnology at Technische Universität Berlin. His research focuses on 3D bioprinting and alternatives to animal experimentation, developing human-relevant models for biomedical research and drug development. He has authored around 150 peer-reviewed publications and received several awards for his work in animal-free research and alternatives to animal testing. He is also Co-Speaker of the Einstein Center 3R, supporting the advancement of the 3Rs and human-relevant research approaches.
Kurreck Headshot
Dr. Dania Movia
Assistant Professor, Biomedical & Health Sciences, Maynooth University | Principal Investigator, Kathleen Lonsdale Institute for Human Health Research
Dr. Dania Movia is an Assistant Professor at Maynooth University and Principal Investigator at the Kathleen Lonsdale Institute for Human Health Research. In 2023, she founded the Humane Biomedical Research Lab, Ireland’s first wet laboratory dedicated entirely to animal-free respiratory research. Her work focuses on human-relevant, non-animal models to improve preclinical research and support the replacement of animal experimentation. Recognised for her leadership in animal-free science, she received the Animal-Free Research UK Outstanding Scientist Award in 2025.
Dania Headshot
Prof. Colin McGuckin
Chief Scientific Officer & President, CTIBIOTECH and CTIBIOTECH USA | Adjunct Professor, Fox Chase Cancer Center
Dr. Dania Movia is an Assistant Professor at Maynooth University and Principal Investigator at the Kathleen Lonsdale Institute for Human Health Research. In 2023, she founded the Humane Biomedical Research Lab, Ireland’s first wet laboratory dedicated entirely to animal-free respiratory research. Her work focuses on human-relevant, non-animal models to improve preclinical research and support the replacement of animal experimentation. Recognised for her leadership in animal-free science, she received the Animal-Free Research UK Outstanding Scientist Award in 2025.
McGuckin Headshot
Pelin Candarlioglu, MSc, PhD
Founder and Director, 3D and 3Rs Ltd.

Pelin Candarlioglu is a translational scientist and regulatory strategist specialising in advanced human-relevant in vitro models. With over 20 years of experience across academia, biotechnology and pharma, she has extensive expertise in microphysiological systems (MPS) and the development of fit-for-purpose models for drug discovery and safety assessment.

She is internationally recognised for advancing the qualification and regulatory adoption of New Approach Methodologies (NAMs). Pelin founded the Regulatory Subgroup of the IQ MPS Affiliate, chairs the EUROoCS Industry Advisory Board, and has worked with organizations including the FDA, EMA and JRC-ECVAM to advance the acceptance of human-relevant models.

Pelin Headshot Burgundy

Information